Bacil Pharma Limited (BOM:524516)
India · Delayed Price · Currency is INR 42.97
+3.47 (8.78%)
At close: Feb 12, 2026
Bacil Pharma Market Cap
Bacil Pharma has a market cap or net worth of 600.82 million as of February 13, 2026. Its market cap has increased by 330.59% in one year.
Market Cap
600.82M
Enterprise Value
584.88M
Revenue
n/a
Ranking
n/a
PE Ratio
67.63
Stock Price
42.97
Market Cap Chart
Since April 23, 2007, Bacil Pharma's market cap has increased from 21.80M to 600.82M, an increase of 2,655.90%. That is a compound annual growth rate of 19.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 600.82M | 17.45% |
| Dec 31, 2025 | 511.54M | 59.83% |
| Dec 31, 2024 | 320.06M | 751.72% |
| Dec 29, 2023 | 37.58M | -32.13% |
| Dec 23, 2022 | 55.37M | 31.47% |
| Dec 31, 2021 | 42.11M | 51.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Panchsheel Organics | 1.52B |
| Tyche Industries | 1.33B |
| Smruthi Organics | 1.32B |
| Krebs Biochemicals & Industries | 1.30B |
| Accretion Nutraveda | 1.22B |
| Resonance Specialties | 1.14B |
| Vasundhara Rasayans | 431.44M |
| Supha Pharmachem | 362.88M |